Lu Han

Partner, Lumira Ventures

Lu is science driven-investor who is passionate about helping entrepreneurs build truly innovative first-in-class life science companies. Having started as an analyst, today Lu is a Partner at Lumira, focused on deal sourcing, due diligence, company building and global partnership initiatives for Lumira portfolio companies.

Prior to joining Lumira, Lu was a co-founder at Sound Options Tinnitus Treatment Inc., an AI-powered digital therapeutics company that developed a non-invasive treatment for disabling neurological diseases. Prior to this, Lu was a strategic consultant at a boutique consultancy firm in the healthcare and life sciences sector, covering both Canadian and International markets.

Lu received his Ph.D. in neuroscience from the University of Toronto followed by post-doctoral studies at the Hospital for Sick Children. Lu is fluent in English, Mandarin, and Chinese. Lu is a board director for following Lumira Ventures portfolio companies: Amacathera, Deka Biosceinces, LQT Therapeutics, Transposon Therapeutics, and Iterion Therapeutics.